Differentiating Alzheimer Disease and Vascular Dementia: Reframing the Question

1997 ◽  
pp. 13-17 ◽  
Author(s):  
Helena Chui ◽  
Qian Zhang ◽  
Jeff Victoroff ◽  
Barbara Zaias
Keyword(s):  
Alzheimer Disease ◽  
Vascular Dementia

scholarly journals P3-087: Late-onset Alzheimer disease and vascular dementia are precociously associated with a derangement in systemic oxidative balance

2015 ◽  
Vol 11 (7S_Part_14) ◽  
pp. P652-P653
Author(s):  
Arianna Romani ◽  
Eleonora Cremonini ◽  
Carlo Cervellati ◽  
Cristina Bosi ◽  
Monica Squerzanti ◽  
...  
Keyword(s):  
Alzheimer Disease ◽  
Vascular Dementia ◽  
Late Onset ◽  
Oxidative Balance

Gender Comparisons of Cognitive Performances Among Vascular Dementia, Alzheimer Disease, and Older Adults Without Dementia

1996 ◽  
Vol 53 (5) ◽  
pp. 436-439 ◽  
Author(s):  
J. G. Buckwalter ◽  
A. A. Rizzo ◽  
R. McCleary ◽  
R. Shankle ◽  
M. Dick ◽  
...  
Keyword(s):  
Older Adults ◽  
Alzheimer Disease ◽  
Vascular Dementia ◽  
Gender Comparisons

Diabetes, Alzheimer disease, and vascular dementia: A population-based neuropathologic study

Neurology ◽  
2010 ◽  
Vol 75 (13) ◽  
pp. 1195-1202 ◽  
Author(s):  
S. Ahtiluoto ◽  
T. Polvikoski ◽  
M. Peltonen ◽  
A. Solomon ◽  
J. Tuomilehto ◽  
...  
Keyword(s):  
Alzheimer Disease ◽  
Vascular Dementia ◽  
Population Based

scholarly journals Use of Antidementia Agents in Vascular Dementia: Beyond Alzheimer Disease

2006 ◽  
Vol 81 (10) ◽  
pp. 1350-1358 ◽  
Author(s):  
Martin R. Farlow
Keyword(s):  
Alzheimer Disease ◽  
Vascular Dementia

Cancer link to Alzheimer disease, but not vascular dementia

2010 ◽  
Vol 6 (3) ◽  
pp. 124-124
Author(s):  
Eleanor Beal
Keyword(s):  
Alzheimer Disease ◽  
Vascular Dementia

Association Between Serum β-Alanine and Risk of Dementia

2019 ◽  
Vol 188 (9) ◽  
pp. 1637-1645 ◽  
Author(s):  
Jun Hata ◽  
Tomoyuki Ohara ◽  
Yoshinori Katakura ◽  
Kuniyoshi Shimizu ◽  
Shuntaro Yamashita ◽  
...  
Keyword(s):  
General Population ◽  
Alzheimer Disease ◽  
Confidence Interval ◽  
Vascular Dementia ◽  
Hazard Ratio ◽  
Inverse Association ◽  
Confounding Factors ◽  
Serum Concentrations ◽  
Elderly Japanese

Abstract We examined the association between serum concentrations of β-alanine, a metabolite of carnosine and anserine, and the risk of dementia in a general population of elderly Japanese persons. In 2007, 1,475 residents of Hisayama, Japan, aged 60–79 years and without dementia were divided into 4 groups according to quartiles of serum β-alanine concentrations (quartile 1, lowest; quartile 4, highest) and followed for a median of 5.3 years. During follow-up, 117 subjects developed all-cause dementia (Alzheimer in 77 cases and vascular dementia in 31). The risk of all-cause dementia decreased with increasing serum β-alanine levels after adjustment for potential confounding factors (quartile 2, hazard ratio (HR) = 0.73 (95% confidence interval (CI): 0.45, 1.18); quartile 3, HR = 0.50 (95% CI: 0.28, 0.89); quartile 4, HR = 0.50 (95% CI: 0.27, 0.92); P = 0.01 for trend). A similar inverse association was observed for Alzheimer disease (quartile 2, HR = 0.78 (95% CI: 0.44, 1.38); quartile 3, HR = 0.53 (95% CI: 0.26, 1.06); quartile 4, HR = 0.53 (95% CI: 0.25, 1.10); P = 0.04 for trend) but not for vascular dementia. We found that higher serum β-alanine levels were significantly associated with lower risks of all-cause dementia and Alzheimer disease. Because serum β-alanine levels reflect intakes of carnosine/anserine, higher intakes of carnosine/anserine might be beneficial for the prevention of dementia.

Sign in / Sign up

Export Citation Format

Share Document